Welcome to the Doctors' Portal
00:00 Sunday
Mediclinic News : CUREVAC'S COVID-19 VACCINE TRIGGERS IMMUNE RESPONSE IN PHASE 1 TRIAL

Title

CUREVAC'S COVID-19 VACCINE TRIGGERS IMMUNE RESPONSE IN PHASE 1 TRIAL

Date

2020-11-03

Link

News Description

TIMESLIVE CureVac's experimental Covid-19 vaccine triggered an immune response in humans, the German biotech firm said on Monday, putting it on track to start mass testing this year as the race to end the pandemic heats up. “We are very encouraged by the interim phase 1 data,” CEO Franz-Werner Haas said in a statement.
Created at 2020/11/10 09:38 AM by Mediclinic
Last modified at 2020/11/10 09:38 AM by Mediclinic